Brain Monitoring Market By Component (Products (Devices (Cerebral Oximeter, Electroencephalogram (EEG) Systems, Electromyography (EMG) Systems, P olysomnographic (PSG) Amplifiers & Recorders, Brain Monitoring Sensors, Transcranial Doppler Devices, Magnetoencephalography (MEG) Systems, Others) Accessories (Cables and Connectors, Electrodes, Batteries, Application Gel, Others)), Software, Services ( Training and Education, Support Services, Others)) By Disease Indication (Sleep Disorder, Epilepsy, Brain Tumor, Stroke, Traumatic Brain Injury (TBI), Others) By Application (Invasive Procedure, Non-Invasive Procedure) By Age Group ( Pediatric, Adult) By End Users (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research Institutions, Home Care, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
The global brain monitoring market is experiencing a sustainable growth due to the rise in geriatric population along with increasing prevalence of neurological disorders such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis and others. According to a survey by Epilepsy Foundation, the average occurrence of epilepsy each year in the US is estimated at 150,000 or 48 for every 100,000 people. In the US, around 3.4 million people are affected by epilepsy conditions which are progressive and their risk increases with age. Brain monitoring instruments are highly complex and expensive as it involves a direct intrusion with the brain tissues. Companies are investing in research and development for non-invasive brain monitoring devices such as CT scan/MRI, ICP monitors, TCD devices and others. For instance, In March 2019, Masimo was granted a CE Mark approval for its next-generation SedLine brain function monitor for pediatric patients aged between one and 18 years of age which evaluates the brain function while the patient is under anesthesia.
Covid-19 has impacted the brain monitoring market as there was a sudden urgency for medical facilities and solutions. This has led to a considerable increase in the demand for remote monitoring solutions. Most of the hospitals/healthcare facilities are currently trying to expand patient monitoring to homecare settings and other temporary setups with an aim to provide basic care. COVID-19 has led to a significant surge in the demand for ventilators, and manufacturers are currently focusing their production to meet the increasing need for ventilators, including other respiratory devices, in divergence to brain monitoring devices. The pandemic is likely to have an negative impact on the brain monitoring business mainly due to the focus of hospitals in setting up COVID-19 specific ICUs (intensive care units) along with the temporary interruption of production and manufacturing sites in major affected regions across the globe.
The increasing infections of Covid-19 has led to a considerable increase in the demand for remote monitoring solutions. As it has been studied that neurological complications are common in critically ill patients with COVID-19 and may result in impaired cerebral hemodynamics. Most of the hospitals and healthcare facilities are currently trying to expand patient monitoring to homecare settings and other temporary setups with an aim to provide basic care. COVID-19 has led to a significant surge in the demand and manufacturers are currently focusing their production to meet the increasing need for ventilators, including other respiratory devices, along with brain monitoring devices. In terms of revenue, brain monitoring market was valued at US$ 6226.74 Mn in 2020 growing at a CAGR of 6.7% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Brain Monitoring Market Revenue & Forecast, (US$ Million), 2015 – 2029
Component Outlook
Based on component, the brain monitoring market is segmented into products, software and services. The products segment, which is further classified into devices and accessories, accounted for the highest share in 2020.The increase in demand for advanced imaging techniques and rise in investments by device manufacturers towards product enhancement has contributed towards the segment’s highest share
Disease Indication Outlook
On the basis of disease indication, brain monitoring market is classified into sleep disorder, epilepsy, brain tumor, stroke, traumatic brain injury (TBI) and others. Traumatic Brain Injury (TBI) held the highest share within the disease indication segment in 2020. TBI is a significant wound which needs immediate brain monitoring treatment within 1-3 days. Therefore, companies are investing in rapid, non-invasive brain scanners that use low-power radio frequency (RF) pulse to detect TBI in short time.
Application Outlook
Based on application, the brain monitoring market is categorized into invasive and non-invasive. The non-invasive segment is expected to show fastest growth during the forecast period. Rise in rates of traumatic brain injuries accompanied with high acceptance rate of minimally invasive devices has increased the demand for these products. Major advancements by the market vendors are also observed within this segment of the market, which also indicates positive growth prospects for the segment over the future years in the global market.
Age Group Outlook
On the basis of age group, global brain monitoring market has been classified into pediatric and adult. Pediatric segment is anticipated to register highest growth rate over the forecast period, while the adult segment held the highest share in 2020. Almost 1.5 to 2 million children are detected with traumatic brain injury (TBI) each year in the United States. Most people who suffer a head injury, about 1.1 million, will have a mild injury that does not require an admission to the hospital. Therefore, for efficient and secondary brain monitoring procedures companies are investing in development of advanced methods.
End Users Outlook
Based on end users, global brain monitoring market is classified into hospitals & clinics, diagnostic centers, ambulatory surgical centers, research institutions, home care and others. Diagnostics centres and home care are estimated to witness highest growth rate over the forecast period. Advancement in technologies have led to the introduction of wireless and portable brain monitoring devices which are suitable for home care, enabling constant monitoring of brain activities. Furthermore, long-term brain monitoring technologies for constantly recording brain activity in both, clinic and home, for disease management among epilepsy patients is providing efficient outcome, thereby advancing its adoption in the global market.
Region Outlook
North America dominated the global brain monitoring market in 2020. However, Asia Pacific is estimated to witness fastest growth rate over the period of next eight years. The Asia Pacific region is witnessing expansion of healthcare facilities as insurance schemes are replacing the conventional out-of-pocket expenses in key countries like India, and China. Moreover, increase in number of geriatric population and growing prevalence of brain disorders in the region are also contributing towards the region’s growth in the global market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global brain monitoring market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the brain monitoring market are Advanced Brain Monitoring, Inc., Compumedics Limited, EMOTIV, GE Healthcare, Koninklijke Philips N.V., Masimo, Medtronic, Natus Medical Incorporated, Neurosoft, and Nihon Kohden Corporation amongst other industry participants.
Global Brain Monitoring Market:
By Component
- Products
- Devices
- Cerebral Oximetry
- Electroencephalogram (EEG) Systems
- Electromyography (EMG) Systems
- Polysomnographic (PSG) Amplifiers & Recorders
- Brain Monitoring Sensors
- Transcranial Doppler Devices
- Magnetoencephalography (MEG) Systems
- Others
- Accessories
- Cables & Connectors
- Electrodes
- Batteries
- Application Gel
- Others
- Software
- Services
- Training & Education
- Support Services
- Others
By Disease Indication
- Sleep Disorder
- Epilepsy
- Brain Tumor
- Stroke
- Traumatic Brain Injury (TBI)
- Others
By Application
- Invasive Procedure
- Non-Invasive Procedure
By Age Group
- Pediatric
- Adult
By End Users
- Hospitals & Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers
- Research Institutions
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Brain Monitoring Market
6. Market Synopsis: Brain
Monitoring Market
7. Brain Monitoring Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Brain Monitoring Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Brain Monitoring Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Brain Monitoring Market
8. Global Brain Monitoring Market Analysis and Forecasts, 2021 –
2029
8.1. Overview
8.1.1. Global
Brain Monitoring Market Revenue (US$ Mn)
8.2. Global
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Component
8.2.1. Products
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Devices, Accessories)
8.2.1.1. Devices
8.2.1.1.1. Cerebral Oximetry
8.2.1.1.2. Electroencephalogram (EEG) Systems
8.2.1.1.3. Electromyography (EMG) Systems
8.2.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
8.2.1.1.5. Brain Monitoring Sensors
8.2.1.1.6. Transcranial Doppler Devices
8.2.1.1.7. Magnetoencephalography (MEG) Systems
8.2.1.1.8. Others
8.2.1.2. Accessories
8.2.1.2.1. Cables and Connectors
8.2.1.2.2. Electrodes
8.2.1.2.3. Batteries
8.2.1.2.4. Application Gel
8.2.1.2.5. Others
8.2.2. Software
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.2.3. Services
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Training and Education, Support
Services, Others)
8.2.3.1. Training and Education
8.2.3.2. Support Services
8.2.3.3. Others
8.3. Key
Segment for Channeling Investments
8.3.1. By
Component
9. Global Brain Monitoring Market Analysis and Forecasts, 2021 –
2029
9.1. Overview
9.2. Global
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Disease Indication
9.2.1. Sleep
Disorder
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Epilepsy
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. Brain
Tumor
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. Stroke
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2020
9.2.4.3. Market Forecast, 2021 - 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.5. Traumatic
Brain Injury (TBI)
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2020
9.2.5.3. Market Forecast, 2021 - 2029
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2020
9.2.5.5.1.2. Market
Forecast, 2021 - 2029
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2020
9.2.5.5.2.2. Market
Forecast, 2021 - 2029
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2020
9.2.5.5.3.2. Market
Forecast, 2021 - 2029
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2020
9.2.5.5.4.2. Market
Forecast, 2021 - 2029
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2020
9.2.5.5.5.2. Market
Forecast, 2021 - 2029
9.2.6. Others
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2020
9.2.6.3. Market Forecast, 2021 - 2029
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North America
9.2.6.5.1.1. Market
Estimation, 2015 - 2020
9.2.6.5.1.2. Market
Forecast, 2021 - 2029
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2020
9.2.6.5.2.2. Market
Forecast, 2021 - 2029
9.2.6.5.3. Asia Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2020
9.2.6.5.3.2. Market
Forecast, 2021 - 2029
9.2.6.5.4. Middle East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2020
9.2.6.5.4.2. Market
Forecast, 2021 - 2029
9.2.6.5.5. Latin America
9.2.6.5.5.1. Market
Estimation, 2015 - 2020
9.2.6.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By
Disease Indication
10. Global Brain Monitoring Market Analysis and Forecasts, 2021 –
2029
10.1. Overview
10.2. Global
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Invasive
Procedure
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Non-Invasive
Procedure
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Brain Monitoring Market Analysis and Forecasts, 2021 –
2029
11.1. Overview
11.2. Global
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Age Group
11.2.1. Pediatric
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2020
11.2.1.3. Market Forecast, 2021 - 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2020
11.2.1.5.1.2. Market
Forecast, 2021 - 2029
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2020
11.2.1.5.2.2. Market
Forecast, 2021 - 2029
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2020
11.2.1.5.3.2. Market
Forecast, 2021 - 2029
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2020
11.2.1.5.4.2. Market
Forecast, 2021 - 2029
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2020
11.2.1.5.5.2. Market
Forecast, 2021 - 2029
11.2.2. Adult
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2020
11.2.2.3. Market Forecast, 2021 - 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2020
11.2.2.5.1.2. Market
Forecast, 2021 - 2029
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2020
11.2.2.5.2.2. Market
Forecast, 2021 - 2029
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2020
11.2.2.5.3.2. Market
Forecast, 2021 - 2029
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2020
11.2.2.5.4.2. Market
Forecast, 2021 - 2029
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2020
11.2.2.5.5.2. Market
Forecast, 2021 - 2029
11.3. Key
Segment for Channeling Investments
11.3.1. By Age
Group
12. Global Brain Monitoring Market Analysis and Forecasts, 2021 –
2029
12.1. Overview
12.2. Global
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By End Users
12.2.1. Hospitals
and Clinics
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2020
12.2.1.3. Market Forecast, 2021 - 2029
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation, 2015 - 2020
12.2.1.5.1.2. Market
Forecast, 2021 - 2029
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2020
12.2.1.5.2.2. Market
Forecast, 2021 - 2029
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2020
12.2.1.5.3.2. Market
Forecast, 2021 - 2029
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2020
12.2.1.5.4.2. Market
Forecast, 2021 - 2029
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation, 2015 - 2020
12.2.1.5.5.2. Market
Forecast, 2021 - 2029
12.2.2. Diagnostic
Centers
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2020
12.2.2.3. Market Forecast, 2021 - 2029
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation, 2015 - 2020
12.2.2.5.1.2. Market
Forecast, 2021 - 2029
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2020
12.2.2.5.2.2. Market
Forecast, 2021 - 2029
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2020
12.2.2.5.3.2. Market
Forecast, 2021 - 2029
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2020
12.2.2.5.4.2. Market
Forecast, 2021 - 2029
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation, 2015 - 2020
12.2.2.5.5.2. Market
Forecast, 2021 - 2029
12.2.3. Ambulatory
Surgical Centers
12.2.3.1. Definition
12.2.3.2. Market Estimation and Penetration, 2015 - 2020
12.2.3.3. Market Forecast, 2021 - 2029
12.2.3.4. Compound Annual Growth Rate (CAGR)
12.2.3.5. Regional Bifurcation
12.2.3.5.1. North America
12.2.3.5.1.1. Market
Estimation, 2015 - 2020
12.2.3.5.1.2. Market
Forecast, 2021 - 2029
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 - 2020
12.2.3.5.2.2. Market
Forecast, 2021 - 2029
12.2.3.5.3. Asia Pacific
12.2.3.5.3.1. Market
Estimation, 2015 - 2020
12.2.3.5.3.2. Market
Forecast, 2021 - 2029
12.2.3.5.4. Middle East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 - 2020
12.2.3.5.4.2. Market
Forecast, 2021 - 2029
12.2.3.5.5. Latin America
12.2.3.5.5.1. Market
Estimation, 2015 - 2020
12.2.3.5.5.2. Market
Forecast, 2021 - 2029
12.2.4. Research
Institutions
12.2.4.1. Definition
12.2.4.2. Market Estimation and Penetration, 2015 - 2020
12.2.4.3. Market Forecast, 2021 - 2029
12.2.4.4. Compound Annual Growth Rate (CAGR)
12.2.4.5. Regional Bifurcation
12.2.4.5.1. North America
12.2.4.5.1.1. Market
Estimation, 2015 - 2020
12.2.4.5.1.2. Market
Forecast, 2021 - 2029
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation, 2015 - 2020
12.2.4.5.2.2. Market
Forecast, 2021 - 2029
12.2.4.5.3. Asia Pacific
12.2.4.5.3.1. Market
Estimation, 2015 - 2020
12.2.4.5.3.2. Market
Forecast, 2021 - 2029
12.2.4.5.4. Middle East and Africa
12.2.4.5.4.1. Market
Estimation, 2015 - 2020
12.2.4.5.4.2. Market
Forecast, 2021 - 2029
12.2.4.5.5. Latin America
12.2.4.5.5.1. Market
Estimation, 2015 - 2020
12.2.4.5.5.2. Market
Forecast, 2021 - 2029
12.2.5. Home
Care
12.2.5.1. Definition
12.2.5.2. Market Estimation and Penetration, 2015 - 2020
12.2.5.3. Market Forecast, 2021 - 2029
12.2.5.4. Compound Annual Growth Rate (CAGR)
12.2.5.5. Regional Bifurcation
12.2.5.5.1. North America
12.2.5.5.1.1. Market
Estimation, 2015 - 2020
12.2.5.5.1.2. Market
Forecast, 2021 - 2029
12.2.5.5.2. Europe
12.2.5.5.2.1. Market
Estimation, 2015 - 2020
12.2.5.5.2.2. Market
Forecast, 2021 - 2029
12.2.5.5.3. Asia Pacific
12.2.5.5.3.1. Market
Estimation, 2015 - 2020
12.2.5.5.3.2. Market
Forecast, 2021 - 2029
12.2.5.5.4. Middle East and Africa
12.2.5.5.4.1. Market
Estimation, 2015 - 2020
12.2.5.5.4.2. Market
Forecast, 2021 - 2029
12.2.5.5.5. Latin America
12.2.5.5.5.1. Market
Estimation, 2015 - 2020
12.2.5.5.5.2. Market
Forecast, 2021 - 2029
12.2.6. Others
12.2.6.1. Definition
12.2.6.2. Market Estimation and Penetration, 2015 - 2020
12.2.6.3. Market Forecast, 2021 - 2029
12.2.6.4. Compound Annual Growth Rate (CAGR)
12.2.6.5. Regional Bifurcation
12.2.6.5.1. North America
12.2.6.5.1.1. Market
Estimation, 2015 - 2020
12.2.6.5.1.2. Market
Forecast, 2021 - 2029
12.2.6.5.2. Europe
12.2.6.5.2.1. Market
Estimation, 2015 - 2020
12.2.6.5.2.2. Market
Forecast, 2021 - 2029
12.2.6.5.3. Asia Pacific
12.2.6.5.3.1. Market
Estimation, 2015 - 2020
12.2.6.5.3.2. Market
Forecast, 2021 - 2029
12.2.6.5.4. Middle East and Africa
12.2.6.5.4.1. Market
Estimation, 2015 - 2020
12.2.6.5.4.2. Market
Forecast, 2021 - 2029
12.2.6.5.5. Latin America
12.2.6.5.5.1. Market
Estimation, 2015 - 2020
12.2.6.5.5.2. Market
Forecast, 2021 - 2029
12.3. Key
Segment for Channeling Investments
12.3.1. By End
Users
13. North America Brain Monitoring Market Analysis and Forecasts,
2021 - 2029
13.1. Overview
13.1.1. North
America Brain Monitoring Market Revenue (US$ Mn)
13.2. North
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Component
13.2.1. Products
13.2.1.1. Devices
13.2.1.1.1. Cerebral Oximetry
13.2.1.1.2. Electroencephalogram (EEG) Systems
13.2.1.1.3. Electromyography (EMG) Systems
13.2.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
13.2.1.1.5. Brain Monitoring Sensors
13.2.1.1.6. Transcranial Doppler Devices
13.2.1.1.7. Magnetoencephalography (MEG) Systems
13.2.1.1.8. Others
13.2.1.2. Accessories
13.2.1.2.1. Cables and Connectors
13.2.1.2.2. Electrodes
13.2.1.2.3. Batteries
13.2.1.2.4. Application Gel
13.2.1.2.5. Others
13.2.2. Software
13.2.3. Services
13.2.3.1. Training and Education
13.2.3.2. Support Services
13.2.3.3. Others
13.3. North
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
13.3.1. Sleep
Disorder
13.3.2. Epilepsy
13.3.3. Brain
Tumor
13.3.4. Stroke
13.3.5. Traumatic
Brain Injury (TBI)
13.3.6. Others
13.4. North
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Invasive
Procedure
13.4.2. Non-Invasive
Procedure
13.5. North
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Age Group
13.5.1. Pediatric
13.5.2. Adult
13.6. North
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1. Hospitals
and Clinics
13.6.2. Diagnostic
Centers
13.6.3. Ambulatory
Surgical Centers
13.6.4. Research
Institutions
13.6.5. Home
Care
13.6.6. Others
13.7. North
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Component
13.7.1.1.1. Products
13.7.1.1.1.1. Devices
13.7.1.1.1.1.1. Cerebral Oximetry
13.7.1.1.1.1.2. Electroencephalogram (EEG) Systems
13.7.1.1.1.1.3. Electromyography (EMG) Systems
13.7.1.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
13.7.1.1.1.1.5. Brain Monitoring Sensors
13.7.1.1.1.1.6. Transcranial Doppler Devices
13.7.1.1.1.1.7. Magnetoencephalography (MEG) Systems
13.7.1.1.1.1.8. Others
13.7.1.1.1.2. Accessories
13.7.1.1.1.2.1. Cables and Connectors
13.7.1.1.1.2.2. Electrodes
13.7.1.1.1.2.3. Batteries
13.7.1.1.1.2.4. Application Gel
13.7.1.1.1.2.5. Others
13.7.1.1.2. Software
13.7.1.1.3. Services
13.7.1.1.3.1. Training
and Education
13.7.1.1.3.2. Support
Services
13.7.1.1.3.3. Others
13.7.1.2. U.S Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
13.7.1.2.1. Sleep Disorder
13.7.1.2.2. Epilepsy
13.7.1.2.3. Brain Tumor
13.7.1.2.4. Stroke
13.7.1.2.5. Traumatic Brain Injury (TBI)
13.7.1.2.6. Others
13.7.1.3. U.S Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.1.3.1. Invasive Procedure
13.7.1.3.2. Non-Invasive Procedure
13.7.1.4. U.S Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Age Group
13.7.1.4.1. Pediatric
13.7.1.4.2. Adult
13.7.1.5. U.S Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
End Users
13.7.1.5.1. Hospitals and Clinics
13.7.1.5.2. Diagnostic Centers
13.7.1.5.3. Ambulatory Surgical Centers
13.7.1.5.4. Research Institutions
13.7.1.5.5. Home Care
13.7.1.5.6. Others
13.7.2. Canada
13.7.2.1. Canada Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
13.7.2.1.1. Products
13.7.2.1.1.1. Devices
13.7.2.1.1.1.1. Cerebral Oximetry
13.7.2.1.1.1.2. Electroencephalogram (EEG) Systems
13.7.2.1.1.1.3. Electromyography (EMG) Systems
13.7.2.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
13.7.2.1.1.1.5. Brain Monitoring Sensors
13.7.2.1.1.1.6. Transcranial Doppler Devices
13.7.2.1.1.1.7. Magnetoencephalography (MEG) Systems
13.7.2.1.1.1.8. Others
13.7.2.1.1.2. Accessories
13.7.2.1.1.2.1. Cables and Connectors
13.7.2.1.1.2.2. Electrodes
13.7.2.1.1.2.3. Batteries
13.7.2.1.1.2.4. Application Gel
13.7.2.1.1.2.5. Others
13.7.2.1.2. Software
13.7.2.1.3. Services
13.7.2.1.3.1. Training
and Education
13.7.2.1.3.2. Support
Services
13.7.2.1.3.3. Others
13.7.2.2. Canada Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
13.7.2.2.1. Sleep Disorder
13.7.2.2.2. Epilepsy
13.7.2.2.3. Brain Tumor
13.7.2.2.4. Stroke
13.7.2.2.5. Traumatic Brain Injury (TBI)
13.7.2.2.6. Others
13.7.2.3. Canada Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
13.7.2.3.1. Invasive Procedure
13.7.2.3.2. Non-Invasive Procedure
13.7.2.4. Canada Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
13.7.2.4.1. Pediatric
13.7.2.4.2. Adult
13.7.2.5. Canada Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
13.7.2.5.1. Hospitals and Clinics
13.7.2.5.2. Diagnostic Centers
13.7.2.5.3. Ambulatory Surgical Centers
13.7.2.5.4. Research Institutions
13.7.2.5.5. Home Care
13.7.2.5.6. Others
13.7.3. Mexico
13.7.3.1. Mexico Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
13.7.3.1.1. Products
13.7.3.1.1.1. Devices
13.7.3.1.1.1.1. Cerebral Oximetry
13.7.3.1.1.1.2. Electroencephalogram (EEG) Systems
13.7.3.1.1.1.3. Electromyography (EMG) Systems
13.7.3.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
13.7.3.1.1.1.5. Brain Monitoring Sensors
13.7.3.1.1.1.6. Transcranial Doppler Devices
13.7.3.1.1.1.7. Magnetoencephalography (MEG) Systems
13.7.3.1.1.1.8. Others
13.7.3.1.1.2. Accessories
13.7.3.1.1.2.1. Cables and Connectors
13.7.3.1.1.2.2. Electrodes
13.7.3.1.1.2.3. Batteries
13.7.3.1.1.2.4. Application Gel
13.7.3.1.1.2.5. Others
13.7.3.1.2. Software
13.7.3.1.3. Services
13.7.3.1.3.1. Training
and Education
13.7.3.1.3.2. Support
Services
13.7.3.1.3.3. Others
13.7.3.2. Mexico Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
13.7.3.2.1. Sleep Disorder
13.7.3.2.2. Epilepsy
13.7.3.2.3. Brain Tumor
13.7.3.2.4. Stroke
13.7.3.2.5. Traumatic Brain Injury (TBI)
13.7.3.2.6. Others
13.7.3.3. Mexico Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
13.7.3.3.1. Invasive Procedure
13.7.3.3.2. Non-Invasive Procedure
13.7.3.4. Mexico Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
13.7.3.4.1. Pediatric
13.7.3.4.2. Adult
13.7.3.5. Mexico Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
13.7.3.5.1. Hospitals and Clinics
13.7.3.5.2. Diagnostic Centers
13.7.3.5.3. Ambulatory Surgical Centers
13.7.3.5.4. Research Institutions
13.7.3.5.5. Home Care
13.7.3.5.6. Others
13.7.4. Rest of
North America
13.7.4.1. Rest of North America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Component
13.7.4.1.1. Products
13.7.4.1.1.1. Devices
13.7.4.1.1.1.1. Cerebral Oximetry
13.7.4.1.1.1.2. Electroencephalogram (EEG) Systems
13.7.4.1.1.1.3. Electromyography (EMG) Systems
13.7.4.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
13.7.4.1.1.1.5. Brain Monitoring Sensors
13.7.4.1.1.1.6. Transcranial Doppler Devices
13.7.4.1.1.1.7. Magnetoencephalography (MEG) Systems
13.7.4.1.1.1.8. Others
13.7.4.1.1.2. Accessories
13.7.4.1.1.2.1. Cables and Connectors
13.7.4.1.1.2.2. Electrodes
13.7.4.1.1.2.3. Batteries
13.7.4.1.1.2.4. Application Gel
13.7.4.1.1.2.5. Others
13.7.4.1.2. Software
13.7.4.1.3. Services
13.7.4.1.3.1. Training
and Education
13.7.4.1.3.2. Support
Services
13.7.4.1.3.3. Others
13.7.4.2. Rest of North America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Disease Indication
13.7.4.2.1. Sleep Disorder
13.7.4.2.2. Epilepsy
13.7.4.2.3. Brain Tumor
13.7.4.2.4. Stroke
13.7.4.2.5. Traumatic Brain Injury (TBI)
13.7.4.2.6. Others
13.7.4.3. Rest of North America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Application
13.7.4.3.1. Invasive Procedure
13.7.4.3.2. Non-Invasive Procedure
13.7.4.4. Rest of North America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Age Group
13.7.4.4.1. Pediatric
13.7.4.4.2. Adult
13.7.4.5. Rest of North America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By End Users
13.7.4.5.1. Hospitals and Clinics
13.7.4.5.2. Diagnostic Centers
13.7.4.5.3. Ambulatory Surgical Centers
13.7.4.5.4. Research Institutions
13.7.4.5.5. Home Care
13.7.4.5.6. Others
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Component
13.8.3. By
Disease Indication
13.8.4. By
Application
13.8.5. By Age
Group
13.8.6. By End
Users
14. Europe Brain Monitoring Market Analysis and Forecasts, 2021 -
2029
14.1. Overview
14.1.1. Europe
Brain Monitoring Market Revenue (US$ Mn)
14.2. Europe
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Component
14.2.1. Products
14.2.1.1. Devices
14.2.1.1.1. Cerebral Oximetry
14.2.1.1.2. Electroencephalogram (EEG) Systems
14.2.1.1.3. Electromyography (EMG) Systems
14.2.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.2.1.1.5. Brain Monitoring Sensors
14.2.1.1.6. Transcranial Doppler Devices
14.2.1.1.7. Magnetoencephalography (MEG) Systems
14.2.1.1.8. Others
14.2.1.2. Accessories
14.2.1.2.1. Cables and Connectors
14.2.1.2.2. Electrodes
14.2.1.2.3. Batteries
14.2.1.2.4. Application Gel
14.2.1.2.5. Others
14.2.2. Software
14.2.3. Services
14.2.3.1. Training and Education
14.2.3.2. Support Services
14.2.3.3. Others
14.3. Europe
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Disease Indication
14.3.1. Sleep
Disorder
14.3.2. Epilepsy
14.3.3. Brain
Tumor
14.3.4. Stroke
14.3.5. Traumatic
Brain Injury (TBI)
14.3.6. Others
14.4. Europe
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Invasive
Procedure
14.4.2. Non-Invasive
Procedure
14.5. Europe
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Age Group
14.5.1. Pediatric
14.5.2. Adult
14.6. Europe
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1. Hospitals
and Clinics
14.6.2. Diagnostic
Centers
14.6.3. Ambulatory
Surgical Centers
14.6.4. Research
Institutions
14.6.5. Home
Care
14.6.6. Others
14.7. Europe
Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
14.7.1.1.1. Products
14.7.1.1.1.1. Devices
14.7.1.1.1.1.1. Cerebral Oximetry
14.7.1.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.1.1.1.1.3. Electromyography (EMG) Systems
14.7.1.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.1.1.1.1.5. Brain Monitoring Sensors
14.7.1.1.1.1.6. Transcranial Doppler Devices
14.7.1.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.1.1.1.1.8. Others
14.7.1.1.1.2. Accessories
14.7.1.1.1.2.1. Cables and Connectors
14.7.1.1.1.2.2. Electrodes
14.7.1.1.1.2.3. Batteries
14.7.1.1.1.2.4. Application Gel
14.7.1.1.1.2.5. Others
14.7.1.1.2. Software
14.7.1.1.3. Services
14.7.1.1.3.1. Training
and Education
14.7.1.1.3.2. Support
Services
14.7.1.1.3.3. Others
14.7.1.2. France Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.7.1.2.1. Sleep Disorder
14.7.1.2.2. Epilepsy
14.7.1.2.3. Brain Tumor
14.7.1.2.4. Stroke
14.7.1.2.5. Traumatic Brain Injury (TBI)
14.7.1.2.6. Others
14.7.1.3. France Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
14.7.1.3.1. Invasive Procedure
14.7.1.3.2. Non-Invasive Procedure
14.7.1.4. France Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
14.7.1.4.1. Pediatric
14.7.1.4.2. Adult
14.7.1.5. France Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.1.5.1. Hospitals and Clinics
14.7.1.5.2. Diagnostic Centers
14.7.1.5.3. Ambulatory Surgical Centers
14.7.1.5.4. Research Institutions
14.7.1.5.5. Home Care
14.7.1.5.6. Others
14.7.2. The UK
14.7.2.1. The UK Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
14.7.2.1.1. Products
14.7.2.1.1.1. Devices
14.7.2.1.1.1.1. Cerebral Oximetry
14.7.2.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.2.1.1.1.3. Electromyography (EMG) Systems
14.7.2.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.2.1.1.1.5. Brain Monitoring Sensors
14.7.2.1.1.1.6. Transcranial Doppler Devices
14.7.2.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.2.1.1.1.8. Others
14.7.2.1.1.2. Accessories
14.7.2.1.1.2.1. Cables and Connectors
14.7.2.1.1.2.2. Electrodes
14.7.2.1.1.2.3. Batteries
14.7.2.1.1.2.4. Application Gel
14.7.2.1.1.2.5. Others
14.7.2.1.2. Software
14.7.2.1.3. Services
14.7.2.1.3.1. Training
and Education
14.7.2.1.3.2. Support
Services
14.7.2.1.3.3. Others
14.7.2.2. The UK Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.7.2.2.1. Sleep Disorder
14.7.2.2.2. Epilepsy
14.7.2.2.3. Brain Tumor
14.7.2.2.4. Stroke
14.7.2.2.5. Traumatic Brain Injury (TBI)
14.7.2.2.6. Others
14.7.2.3. The UK Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
14.7.2.3.1. Invasive Procedure
14.7.2.3.2. Non-Invasive Procedure
14.7.2.4. The UK Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
14.7.2.4.1. Pediatric
14.7.2.4.2. Adult
14.7.2.5. The UK Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.2.5.1. Hospitals and Clinics
14.7.2.5.2. Diagnostic Centers
14.7.2.5.3. Ambulatory Surgical Centers
14.7.2.5.4. Research Institutions
14.7.2.5.5. Home Care
14.7.2.5.6. Others
14.7.3. Spain
14.7.3.1. Spain Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
14.7.3.1.1. Products
14.7.3.1.1.1. Devices
14.7.3.1.1.1.1. Cerebral Oximetry
14.7.3.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.3.1.1.1.3. Electromyography (EMG) Systems
14.7.3.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.3.1.1.1.5. Brain Monitoring Sensors
14.7.3.1.1.1.6. Transcranial Doppler Devices
14.7.3.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.3.1.1.1.8. Others
14.7.3.1.1.2. Accessories
14.7.3.1.1.2.1. Cables and Connectors
14.7.3.1.1.2.2. Electrodes
14.7.3.1.1.2.3. Batteries
14.7.3.1.1.2.4. Application Gel
14.7.3.1.1.2.5. Others
14.7.3.1.2. Software
14.7.3.1.3. Services
14.7.3.1.3.1. Training
and Education
14.7.3.1.3.2. Support
Services
14.7.3.1.3.3. Others
14.7.3.2. Spain Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.7.3.2.1. Sleep Disorder
14.7.3.2.2. Epilepsy
14.7.3.2.3. Brain Tumor
14.7.3.2.4. Stroke
14.7.3.2.5. Traumatic Brain Injury (TBI)
14.7.3.2.6. Others
14.7.3.3. Spain Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
14.7.3.3.1. Invasive Procedure
14.7.3.3.2. Non-Invasive Procedure
14.7.3.4. Spain Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
14.7.3.4.1. Pediatric
14.7.3.4.2. Adult
14.7.3.5. Spain Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.3.5.1. Hospitals and Clinics
14.7.3.5.2. Diagnostic Centers
14.7.3.5.3. Ambulatory Surgical Centers
14.7.3.5.4. Research Institutions
14.7.3.5.5. Home Care
14.7.3.5.6. Others
14.7.4. Germany
14.7.4.1. Germany Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
14.7.4.1.1. Products
14.7.4.1.1.1. Devices
14.7.4.1.1.1.1. Cerebral Oximetry
14.7.4.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.4.1.1.1.3. Electromyography (EMG) Systems
14.7.4.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.4.1.1.1.5. Brain Monitoring Sensors
14.7.4.1.1.1.6. Transcranial Doppler Devices
14.7.4.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.4.1.1.1.8. Others
14.7.4.1.1.2. Accessories
14.7.4.1.1.2.1. Cables and Connectors
14.7.4.1.1.2.2. Electrodes
14.7.4.1.1.2.3. Batteries
14.7.4.1.1.2.4. Application Gel
14.7.4.1.1.2.5. Others
14.7.4.1.2. Software
14.7.4.1.3. Services
14.7.4.1.3.1. Training
and Education
14.7.4.1.3.2. Support
Services
14.7.4.1.3.3. Others
14.7.4.2. Germany Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.7.4.2.1. Sleep Disorder
14.7.4.2.2. Epilepsy
14.7.4.2.3. Brain Tumor
14.7.4.2.4. Stroke
14.7.4.2.5. Traumatic Brain Injury (TBI)
14.7.4.2.6. Others
14.7.4.3. Germany Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.4.3.1. Invasive Procedure
14.7.4.3.2. Non-Invasive Procedure
14.7.4.4. Germany Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.7.4.4.1. Pediatric
14.7.4.4.2. Adult
14.7.4.5. Germany Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.4.5.1. Hospitals and Clinics
14.7.4.5.2. Diagnostic Centers
14.7.4.5.3. Ambulatory Surgical Centers
14.7.4.5.4. Research Institutions
14.7.4.5.5. Home Care
14.7.4.5.6. Others
14.7.5. Italy
14.7.5.1. Italy Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
14.7.5.1.1. Products
14.7.5.1.1.1. Devices
14.7.5.1.1.1.1. Cerebral Oximetry
14.7.5.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.5.1.1.1.3. Electromyography (EMG) Systems
14.7.5.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.5.1.1.1.5. Brain Monitoring Sensors
14.7.5.1.1.1.6. Transcranial Doppler Devices
14.7.5.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.5.1.1.1.8. Others
14.7.5.1.1.2. Accessories
14.7.5.1.1.2.1. Cables and Connectors
14.7.5.1.1.2.2. Electrodes
14.7.5.1.1.2.3. Batteries
14.7.5.1.1.2.4. Application Gel
14.7.5.1.1.2.5. Others
14.7.5.1.2. Software
14.7.5.1.3. Services
14.7.5.1.3.1. Training
and Education
14.7.5.1.3.2. Support
Services
14.7.5.1.3.3. Others
14.7.5.2. Italy Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.7.5.2.1. Sleep Disorder
14.7.5.2.2. Epilepsy
14.7.5.2.3. Brain Tumor
14.7.5.2.4. Stroke
14.7.5.2.5. Traumatic Brain Injury (TBI)
14.7.5.2.6. Others
14.7.5.3. Italy Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
14.7.5.3.1. Invasive Procedure
14.7.5.3.2. Non-Invasive Procedure
14.7.5.4. Italy Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
14.7.5.4.1. Pediatric
14.7.5.4.2. Adult
14.7.5.5. Italy Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
14.7.5.5.1. Hospitals and Clinics
14.7.5.5.2. Diagnostic Centers
14.7.5.5.3. Ambulatory Surgical Centers
14.7.5.5.4. Research Institutions
14.7.5.5.5. Home Care
14.7.5.5.6. Others
14.7.6. Nordic
Countries
14.7.6.1. Nordic Countries Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
14.7.6.1.1. Products
14.7.6.1.1.1. Devices
14.7.6.1.1.1.1. Cerebral Oximetry
14.7.6.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.6.1.1.1.3. Electromyography (EMG) Systems
14.7.6.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.6.1.1.1.5. Brain Monitoring Sensors
14.7.6.1.1.1.6. Transcranial Doppler Devices
14.7.6.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.6.1.1.1.8. Others
14.7.6.1.1.2. Accessories
14.7.6.1.1.2.1. Cables and Connectors
14.7.6.1.1.2.2. Electrodes
14.7.6.1.1.2.3. Batteries
14.7.6.1.1.2.4. Application Gel
14.7.6.1.1.2.5. Others
14.7.6.1.2. Software
14.7.6.1.3. Services
14.7.6.1.3.1. Training
and Education
14.7.6.1.3.2. Support
Services
14.7.6.1.3.3. Others
14.7.6.2. Nordic Countries Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.7.6.2.1. Sleep Disorder
14.7.6.2.2. Epilepsy
14.7.6.2.3. Brain Tumor
14.7.6.2.4. Stroke
14.7.6.2.5. Traumatic Brain Injury (TBI)
14.7.6.2.6. Others
14.7.6.3. Nordic Countries Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.6.3.1. Invasive Procedure
14.7.6.3.2. Non-Invasive Procedure
14.7.6.4. Nordic Countries Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.7.6.4.1. Pediatric
14.7.6.4.2. Adult
14.7.6.5. Nordic Countries Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.6.5.1. Hospitals and Clinics
14.7.6.5.2. Diagnostic Centers
14.7.6.5.3. Ambulatory Surgical Centers
14.7.6.5.4. Research Institutions
14.7.6.5.5. Home Care
14.7.6.5.6. Others
14.7.6.6. Nordic Countries Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux Union Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
14.7.7.1.1. Products
14.7.7.1.1.1. Devices
14.7.7.1.1.1.1. Cerebral Oximetry
14.7.7.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.7.1.1.1.3. Electromyography (EMG) Systems
14.7.7.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.7.1.1.1.5. Brain Monitoring Sensors
14.7.7.1.1.1.6. Transcranial Doppler Devices
14.7.7.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.7.1.1.1.8. Others
14.7.7.1.1.2. Accessories
14.7.7.1.1.2.1. Cables and Connectors
14.7.7.1.1.2.2. Electrodes
14.7.7.1.1.2.3. Batteries
14.7.7.1.1.2.4. Application Gel
14.7.7.1.1.2.5. Others
14.7.7.1.2. Software
14.7.7.1.3. Services
14.7.7.1.3.1. Training
and Education
14.7.7.1.3.2. Support
Services
14.7.7.1.3.3. Others
14.7.7.2. Benelux Union Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.7.7.2.1. Sleep Disorder
14.7.7.2.2. Epilepsy
14.7.7.2.3. Brain Tumor
14.7.7.2.4. Stroke
14.7.7.2.5. Traumatic Brain Injury (TBI)
14.7.7.2.6. Others
14.7.7.3. Benelux Union Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.7.3.1. Invasive Procedure
14.7.7.3.2. Non-Invasive Procedure
14.7.7.4. Benelux Union Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.7.7.4.1. Pediatric
14.7.7.4.2. Adult
14.7.7.5. Benelux Union Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.7.5.1. Hospitals and Clinics
14.7.7.5.2. Diagnostic Centers
14.7.7.5.3. Ambulatory Surgical Centers
14.7.7.5.4. Research Institutions
14.7.7.5.5. Home Care
14.7.7.5.6. Others
14.7.7.6. Benelux Union Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest of Europe Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
14.7.8.1.1. Products
14.7.8.1.1.1. Devices
14.7.8.1.1.1.1. Cerebral Oximetry
14.7.8.1.1.1.2. Electroencephalogram (EEG) Systems
14.7.8.1.1.1.3. Electromyography (EMG) Systems
14.7.8.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
14.7.8.1.1.1.5. Brain Monitoring Sensors
14.7.8.1.1.1.6. Transcranial Doppler Devices
14.7.8.1.1.1.7. Magnetoencephalography (MEG) Systems
14.7.8.1.1.1.8. Others
14.7.8.1.1.2. Accessories
14.7.8.1.1.2.1. Cables and Connectors
14.7.8.1.1.2.2. Electrodes
14.7.8.1.1.2.3. Batteries
14.7.8.1.1.2.4. Application Gel
14.7.8.1.1.2.5. Others
14.7.8.1.2. Software
14.7.8.1.3. Services
14.7.8.1.3.1. Training
and Education
14.7.8.1.3.2. Support
Services
14.7.8.1.3.3. Others
14.7.8.2. Rest of Europe Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.7.8.2.1. Sleep Disorder
14.7.8.2.2. Epilepsy
14.7.8.2.3. Brain Tumor
14.7.8.2.4. Stroke
14.7.8.2.5. Traumatic Brain Injury (TBI)
14.7.8.2.6. Others
14.7.8.3. Rest of Europe Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.8.3.1. Invasive Procedure
14.7.8.3.2. Non-Invasive Procedure
14.7.8.4. Rest of Europe Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.7.8.4.1. Pediatric
14.7.8.4.2. Adult
14.7.8.5. Rest of Europe Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.8.5.1. Hospitals and Clinics
14.7.8.5.2. Diagnostic Centers
14.7.8.5.3. Ambulatory Surgical Centers
14.7.8.5.4. Research Institutions
14.7.8.5.5. Home Care
14.7.8.5.6. Others
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By Component
14.8.3. By
Disease Indication
14.8.4. By
Application
14.8.5. By Age
Group
14.8.6. By End
Users
15. Asia Pacific Brain Monitoring Market Analysis and Forecasts,
2021 - 2029
15.1. Overview
15.1.1. Asia
Pacific Brain Monitoring Market Revenue (US$ Mn)
15.2. Asia
Pacific Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Component
15.2.1. Products
15.2.1.1. Devices
15.2.1.1.1. Cerebral Oximetry
15.2.1.1.2. Electroencephalogram (EEG) Systems
15.2.1.1.3. Electromyography (EMG) Systems
15.2.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.2.1.1.5. Brain Monitoring Sensors
15.2.1.1.6. Transcranial Doppler Devices
15.2.1.1.7. Magnetoencephalography (MEG) Systems
15.2.1.1.8. Others
15.2.1.2. Accessories
15.2.1.2.1. Cables and Connectors
15.2.1.2.2. Electrodes
15.2.1.2.3. Batteries
15.2.1.2.4. Application Gel
15.2.1.2.5. Others
15.2.2. Software
15.2.3. Services
15.2.3.1. Training and Education
15.2.3.2. Support Services
15.2.3.3. Others
15.3. Asia
Pacific Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
15.3.1. Sleep
Disorder
15.3.2. Epilepsy
15.3.3. Brain
Tumor
15.3.4. Stroke
15.3.5. Traumatic
Brain Injury (TBI)
15.3.6. Others
15.4. Asia
Pacific Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Invasive
Procedure
15.4.2. Non-Invasive
Procedure
15.5. Asia
Pacific Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Age Group
15.5.1. Pediatric
15.5.2. Adult
15.6. Asia
Pacific Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.1. Hospitals
and Clinics
15.6.2. Diagnostic
Centers
15.6.3. Ambulatory
Surgical Centers
15.6.4. Research
Institutions
15.6.5. Home
Care
15.6.6. Others
15.7. Asia
Pacific Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
15.7.1.1.1. Products
15.7.1.1.1.1. Devices
15.7.1.1.1.1.1. Cerebral Oximetry
15.7.1.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.1.1.1.1.3. Electromyography (EMG) Systems
15.7.1.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.1.1.1.1.5. Brain Monitoring Sensors
15.7.1.1.1.1.6. Transcranial Doppler Devices
15.7.1.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.1.1.1.1.8. Others
15.7.1.1.1.2. Accessories
15.7.1.1.1.2.1. Cables and Connectors
15.7.1.1.1.2.2. Electrodes
15.7.1.1.1.2.3. Batteries
15.7.1.1.1.2.4. Application Gel
15.7.1.1.1.2.5. Others
15.7.1.1.2. Software
15.7.1.1.3. Services
15.7.1.1.3.1. Training
and Education
15.7.1.1.3.2. Support
Services
15.7.1.1.3.3. Others
15.7.1.2. China Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
15.7.1.2.1. Sleep Disorder
15.7.1.2.2. Epilepsy
15.7.1.2.3. Brain Tumor
15.7.1.2.4. Stroke
15.7.1.2.5. Traumatic Brain Injury (TBI)
15.7.1.2.6. Others
15.7.1.3. China Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
15.7.1.3.1. Invasive Procedure
15.7.1.3.2. Non-Invasive Procedure
15.7.1.4. China Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
15.7.1.4.1. Pediatric
15.7.1.4.2. Adult
15.7.1.5. China Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.1.5.1. Hospitals and Clinics
15.7.1.5.2. Diagnostic Centers
15.7.1.5.3. Ambulatory Surgical Centers
15.7.1.5.4. Research Institutions
15.7.1.5.5. Home Care
15.7.1.5.6. Others
15.7.2. Japan
15.7.2.1. Japan Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
15.7.2.1.1. Products
15.7.2.1.1.1. Devices
15.7.2.1.1.1.1. Cerebral Oximetry
15.7.2.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.2.1.1.1.3. Electromyography (EMG) Systems
15.7.2.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.2.1.1.1.5. Brain Monitoring Sensors
15.7.2.1.1.1.6. Transcranial Doppler Devices
15.7.2.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.2.1.1.1.8. Others
15.7.2.1.1.2. Accessories
15.7.2.1.1.2.1. Cables and Connectors
15.7.2.1.1.2.2. Electrodes
15.7.2.1.1.2.3. Batteries
15.7.2.1.1.2.4. Application Gel
15.7.2.1.1.2.5. Others
15.7.2.1.2. Software
15.7.2.1.3. Services
15.7.2.1.3.1. Training
and Education
15.7.2.1.3.2. Support
Services
15.7.2.1.3.3. Others
15.7.2.2. Japan Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
15.7.2.2.1. Sleep Disorder
15.7.2.2.2. Epilepsy
15.7.2.2.3. Brain Tumor
15.7.2.2.4. Stroke
15.7.2.2.5. Traumatic Brain Injury (TBI)
15.7.2.2.6. Others
15.7.2.3. Japan Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
15.7.2.3.1. Invasive Procedure
15.7.2.3.2. Non-Invasive Procedure
15.7.2.4. Japan Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
15.7.2.4.1. Pediatric
15.7.2.4.2. Adult
15.7.2.5. Japan Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.2.5.1. Hospitals and Clinics
15.7.2.5.2. Diagnostic Centers
15.7.2.5.3. Ambulatory Surgical Centers
15.7.2.5.4. Research Institutions
15.7.2.5.5. Home Care
15.7.2.5.6. Others
15.7.3. India
15.7.3.1. India Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
15.7.3.1.1. Products
15.7.3.1.1.1. Devices
15.7.3.1.1.1.1. Cerebral Oximetry
15.7.3.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.3.1.1.1.3. Electromyography (EMG) Systems
15.7.3.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.3.1.1.1.5. Brain Monitoring Sensors
15.7.3.1.1.1.6. Transcranial Doppler Devices
15.7.3.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.3.1.1.1.8. Others
15.7.3.1.1.2. Accessories
15.7.3.1.1.2.1. Cables and Connectors
15.7.3.1.1.2.2. Electrodes
15.7.3.1.1.2.3. Batteries
15.7.3.1.1.2.4. Application Gel
15.7.3.1.1.2.5. Others
15.7.3.1.2. Software
15.7.3.1.3. Services
15.7.3.1.3.1. Training
and Education
15.7.3.1.3.2. Support
Services
15.7.3.1.3.3. Others
15.7.3.2. India Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
15.7.3.2.1. Sleep Disorder
15.7.3.2.2. Epilepsy
15.7.3.2.3. Brain Tumor
15.7.3.2.4. Stroke
15.7.3.2.5. Traumatic Brain Injury (TBI)
15.7.3.2.6. Others
15.7.3.3. India Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
15.7.3.3.1. Invasive Procedure
15.7.3.3.2. Non-Invasive Procedure
15.7.3.4. India Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
15.7.3.4.1. Pediatric
15.7.3.4.2. Adult
15.7.3.5. India Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
15.7.3.5.1. Hospitals and Clinics
15.7.3.5.2. Diagnostic Centers
15.7.3.5.3. Ambulatory Surgical Centers
15.7.3.5.4. Research Institutions
15.7.3.5.5. Home Care
15.7.3.5.6. Others
15.7.4. New
Zealand
15.7.4.1. New Zealand Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
15.7.4.1.1. Products
15.7.4.1.1.1. Devices
15.7.4.1.1.1.1. Cerebral Oximetry
15.7.4.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.4.1.1.1.3. Electromyography (EMG) Systems
15.7.4.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.4.1.1.1.5. Brain Monitoring Sensors
15.7.4.1.1.1.6. Transcranial Doppler Devices
15.7.4.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.4.1.1.1.8. Others
15.7.4.1.1.2. Accessories
15.7.4.1.1.2.1. Cables and Connectors
15.7.4.1.1.2.2. Electrodes
15.7.4.1.1.2.3. Batteries
15.7.4.1.1.2.4. Application Gel
15.7.4.1.1.2.5. Others
15.7.4.1.2. Software
15.7.4.1.3. Services
15.7.4.1.3.1. Training
and Education
15.7.4.1.3.2. Support
Services
15.7.4.1.3.3. Others
15.7.4.2. New Zealand Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
15.7.4.2.1. Sleep Disorder
15.7.4.2.2. Epilepsy
15.7.4.2.3. Brain Tumor
15.7.4.2.4. Stroke
15.7.4.2.5. Traumatic Brain Injury (TBI)
15.7.4.2.6. Others
15.7.4.3. New Zealand Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.4.3.1. Invasive Procedure
15.7.4.3.2. Non-Invasive Procedure
15.7.4.4. New Zealand Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
15.7.4.4.1. Pediatric
15.7.4.4.2. Adult
15.7.4.5. New Zealand Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.4.5.1. Hospitals and Clinics
15.7.4.5.2. Diagnostic Centers
15.7.4.5.3. Ambulatory Surgical Centers
15.7.4.5.4. Research Institutions
15.7.4.5.5. Home Care
15.7.4.5.6. Others
15.7.5. Australia
15.7.5.1. Australia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
15.7.5.1.1. Products
15.7.5.1.1.1. Devices
15.7.5.1.1.1.1. Cerebral Oximetry
15.7.5.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.5.1.1.1.3. Electromyography (EMG) Systems
15.7.5.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.5.1.1.1.5. Brain Monitoring Sensors
15.7.5.1.1.1.6. Transcranial Doppler Devices
15.7.5.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.5.1.1.1.8. Others
15.7.5.1.1.2. Accessories
15.7.5.1.1.2.1. Cables and Connectors
15.7.5.1.1.2.2. Electrodes
15.7.5.1.1.2.3. Batteries
15.7.5.1.1.2.4. Application Gel
15.7.5.1.1.2.5. Others
15.7.5.1.2. Software
15.7.5.1.3. Services
15.7.5.1.3.1. Training
and Education
15.7.5.1.3.2. Support
Services
15.7.5.1.3.3. Others
15.7.5.2. Australia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
15.7.5.2.1. Sleep Disorder
15.7.5.2.2. Epilepsy
15.7.5.2.3. Brain Tumor
15.7.5.2.4. Stroke
15.7.5.2.5. Traumatic Brain Injury (TBI)
15.7.5.2.6. Others
15.7.5.3. Australia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.5.3.1. Invasive Procedure
15.7.5.3.2. Non-Invasive Procedure
15.7.5.4. Australia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
15.7.5.4.1. Pediatric
15.7.5.4.2. Adult
15.7.5.5. Australia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.5.5.1. Hospitals and Clinics
15.7.5.5.2. Diagnostic Centers
15.7.5.5.3. Ambulatory Surgical Centers
15.7.5.5.4. Research Institutions
15.7.5.5.5. Home Care
15.7.5.5.6. Others
15.7.6. South
Korea
15.7.6.1. South Korea Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
15.7.6.1.1. Products
15.7.6.1.1.1. Devices
15.7.6.1.1.1.1. Cerebral Oximetry
15.7.6.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.6.1.1.1.3. Electromyography (EMG) Systems
15.7.6.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.6.1.1.1.5. Brain Monitoring Sensors
15.7.6.1.1.1.6. Transcranial Doppler Devices
15.7.6.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.6.1.1.1.8. Others
15.7.6.1.1.2. Accessories
15.7.6.1.1.2.1. Cables and Connectors
15.7.6.1.1.2.2. Electrodes
15.7.6.1.1.2.3. Batteries
15.7.6.1.1.2.4. Application Gel
15.7.6.1.1.2.5. Others
15.7.6.1.2. Software
15.7.6.1.3. Services
15.7.6.1.3.1. Training
and Education
15.7.6.1.3.2. Support
Services
15.7.6.1.3.3. Others
15.7.6.2. South Korea Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
15.7.6.2.1. Sleep Disorder
15.7.6.2.2. Epilepsy
15.7.6.2.3. Brain Tumor
15.7.6.2.4. Stroke
15.7.6.2.5. Traumatic Brain Injury (TBI)
15.7.6.2.6. Others
15.7.6.3. South Korea Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.6.3.1. Invasive Procedure
15.7.6.3.2. Non-Invasive Procedure
15.7.6.4. South Korea Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
15.7.6.4.1. Pediatric
15.7.6.4.2. Adult
15.7.6.5. South Korea Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.6.5.1. Hospitals and Clinics
15.7.6.5.2. Diagnostic Centers
15.7.6.5.3. Ambulatory Surgical Centers
15.7.6.5.4. Research Institutions
15.7.6.5.5. Home Care
15.7.6.5.6. Others
15.7.7. Southeast
Asia
15.7.7.1. Southeast Asia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
15.7.7.1.1. Products
15.7.7.1.1.1. Devices
15.7.7.1.1.1.1. Cerebral Oximetry
15.7.7.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.7.1.1.1.3. Electromyography (EMG) Systems
15.7.7.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.7.1.1.1.5. Brain Monitoring Sensors
15.7.7.1.1.1.6. Transcranial Doppler Devices
15.7.7.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.7.1.1.1.8. Others
15.7.7.1.1.2. Accessories
15.7.7.1.1.2.1. Cables and Connectors
15.7.7.1.1.2.2. Electrodes
15.7.7.1.1.2.3. Batteries
15.7.7.1.1.2.4. Application Gel
15.7.7.1.1.2.5. Others
15.7.7.1.2. Software
15.7.7.1.3. Services
15.7.7.1.3.1. Training
and Education
15.7.7.1.3.2. Support
Services
15.7.7.1.3.3. Others
15.7.7.2. Southeast Asia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
15.7.7.2.1. Sleep Disorder
15.7.7.2.2. Epilepsy
15.7.7.2.3. Brain Tumor
15.7.7.2.4. Stroke
15.7.7.2.5. Traumatic Brain Injury (TBI)
15.7.7.2.6. Others
15.7.7.3. Southeast Asia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.7.3.1. Invasive Procedure
15.7.7.3.2. Non-Invasive Procedure
15.7.7.4. Southeast Asia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
15.7.7.4.1. Pediatric
15.7.7.4.2. Adult
15.7.7.5. Southeast Asia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.7.5.1. Hospitals and Clinics
15.7.7.5.2. Diagnostic Centers
15.7.7.5.3. Ambulatory Surgical Centers
15.7.7.5.4. Research Institutions
15.7.7.5.5. Home Care
15.7.7.5.6. Others
15.7.7.6. Southeast Asia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest of Asia Pacific Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Component
15.7.8.1.1. Products
15.7.8.1.1.1. Devices
15.7.8.1.1.1.1. Cerebral Oximetry
15.7.8.1.1.1.2. Electroencephalogram (EEG) Systems
15.7.8.1.1.1.3. Electromyography (EMG) Systems
15.7.8.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
15.7.8.1.1.1.5. Brain Monitoring Sensors
15.7.8.1.1.1.6. Transcranial Doppler Devices
15.7.8.1.1.1.7. Magnetoencephalography (MEG) Systems
15.7.8.1.1.1.8. Others
15.7.8.1.1.2. Accessories
15.7.8.1.1.2.1. Cables and Connectors
15.7.8.1.1.2.2. Electrodes
15.7.8.1.1.2.3. Batteries
15.7.8.1.1.2.4. Application Gel
15.7.8.1.1.2.5. Others
15.7.8.1.2. Software
15.7.8.1.3. Services
15.7.8.1.3.1. Training
and Education
15.7.8.1.3.2. Support
Services
15.7.8.1.3.3. Others
15.7.8.2. Rest of Asia Pacific Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Disease Indication
15.7.8.2.1. Sleep Disorder
15.7.8.2.2. Epilepsy
15.7.8.2.3. Brain Tumor
15.7.8.2.4. Stroke
15.7.8.2.5. Traumatic Brain Injury (TBI)
15.7.8.2.6. Others
15.7.8.3. Rest of Asia Pacific Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.8.3.1. Invasive Procedure
15.7.8.3.2. Non-Invasive Procedure
15.7.8.4. Rest of Asia Pacific Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Age Group
15.7.8.4.1. Pediatric
15.7.8.4.2. Adult
15.7.8.5. Rest of Asia Pacific Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By End Users
15.7.8.5.1. Hospitals and Clinics
15.7.8.5.2. Diagnostic Centers
15.7.8.5.3. Ambulatory Surgical Centers
15.7.8.5.4. Research Institutions
15.7.8.5.5. Home Care
15.7.8.5.6. Others
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By
Component
15.8.3. By
Disease Indication
15.8.4. By
Application
15.8.5. By Age
Group
15.8.6. By End
Users
16. Middle East and Africa Brain Monitoring Market Analysis and
Forecasts, 2021 - 2029
16.1. Overview
16.1.1. Middle
East and Africa Brain Monitoring Market Revenue (US$ Mn)
16.2. Middle
East and Africa Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Component
16.2.1. Products
16.2.1.1. Devices
16.2.1.1.1. Cerebral Oximetry
16.2.1.1.2. Electroencephalogram (EEG) Systems
16.2.1.1.3. Electromyography (EMG) Systems
16.2.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
16.2.1.1.5. Brain Monitoring Sensors
16.2.1.1.6. Transcranial Doppler Devices
16.2.1.1.7. Magnetoencephalography (MEG) Systems
16.2.1.1.8. Others
16.2.1.2. Accessories
16.2.1.2.1. Cables and Connectors
16.2.1.2.2. Electrodes
16.2.1.2.3. Batteries
16.2.1.2.4. Application Gel
16.2.1.2.5. Others
16.2.2. Software
16.2.3. Services
16.2.3.1. Training and Education
16.2.3.2. Support Services
16.2.3.3. Others
16.3. Middle
East and Africa Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
16.3.1. Sleep
Disorder
16.3.2. Epilepsy
16.3.3. Brain
Tumor
16.3.4. Stroke
16.3.5. Traumatic
Brain Injury (TBI)
16.3.6. Others
16.4. Middle
East and Africa Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Application
16.4.1. Invasive
Procedure
16.4.2. Non-Invasive
Procedure
16.5. Middle
East and Africa Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.5.1. Pediatric
16.5.2. Adult
16.6. Middle
East and Africa Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By End
Users
16.6.1. Hospitals
and Clinics
16.6.2. Diagnostic
Centers
16.6.3. Ambulatory
Surgical Centers
16.6.4. Research
Institutions
16.6.5. Home
Care
16.6.6. Others
16.7. Middle
East and Africa Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Country
16.7.1. Saudi Arabia
16.7.1.1. Saudi Arabia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
16.7.1.1.1. Products
16.7.1.1.1.1. Devices
16.7.1.1.1.1.1. Cerebral Oximetry
16.7.1.1.1.1.2. Electroencephalogram (EEG) Systems
16.7.1.1.1.1.3. Electromyography (EMG) Systems
16.7.1.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
16.7.1.1.1.1.5. Brain Monitoring Sensors
16.7.1.1.1.1.6. Transcranial Doppler Devices
16.7.1.1.1.1.7. Magnetoencephalography (MEG) Systems
16.7.1.1.1.1.8. Others
16.7.1.1.1.2. Accessories
16.7.1.1.1.2.1. Cables and Connectors
16.7.1.1.1.2.2. Electrodes
16.7.1.1.1.2.3. Batteries
16.7.1.1.1.2.4. Application Gel
16.7.1.1.1.2.5. Others
16.7.1.1.2. Software
16.7.1.1.3. Services
16.7.1.1.3.1. Training
and Education
16.7.1.1.3.2. Support
Services
16.7.1.1.3.3. Others
16.7.1.2. Saudi Arabia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
16.7.1.2.1. Sleep Disorder
16.7.1.2.2. Epilepsy
16.7.1.2.3. Brain Tumor
16.7.1.2.4. Stroke
16.7.1.2.5. Traumatic Brain Injury (TBI)
16.7.1.2.6. Others
16.7.1.3. Saudi Arabia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.1.3.1. Invasive Procedure
16.7.1.3.2. Non-Invasive Procedure
16.7.1.4. Saudi Arabia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
16.7.1.4.1. Pediatric
16.7.1.4.2. Adult
16.7.1.5. Saudi Arabia Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.1.5.1. Hospitals and Clinics
16.7.1.5.2. Diagnostic Centers
16.7.1.5.3. Ambulatory Surgical Centers
16.7.1.5.4. Research Institutions
16.7.1.5.5. Home Care
16.7.1.5.6. Others
16.7.2. UAE
16.7.2.1. UAE Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Component
16.7.2.1.1. Products
16.7.2.1.1.1. Devices
16.7.2.1.1.1.1. Cerebral Oximetry
16.7.2.1.1.1.2. Electroencephalogram (EEG) Systems
16.7.2.1.1.1.3. Electromyography (EMG) Systems
16.7.2.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
16.7.2.1.1.1.5. Brain Monitoring Sensors
16.7.2.1.1.1.6. Transcranial Doppler Devices
16.7.2.1.1.1.7. Magnetoencephalography (MEG) Systems
16.7.2.1.1.1.8. Others
16.7.2.1.1.2. Accessories
16.7.2.1.1.2.1. Cables and Connectors
16.7.2.1.1.2.2. Electrodes
16.7.2.1.1.2.3. Batteries
16.7.2.1.1.2.4. Application Gel
16.7.2.1.1.2.5. Others
16.7.2.1.2. Software
16.7.2.1.3. Services
16.7.2.1.3.1. Training
and Education
16.7.2.1.3.2. Support
Services
16.7.2.1.3.3. Others
16.7.2.2. UAE Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
16.7.2.2.1. Sleep Disorder
16.7.2.2.2. Epilepsy
16.7.2.2.3. Brain Tumor
16.7.2.2.4. Stroke
16.7.2.2.5. Traumatic Brain Injury (TBI)
16.7.2.2.6. Others
16.7.2.3. UAE Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Application
16.7.2.3.1. Invasive Procedure
16.7.2.3.2. Non-Invasive Procedure
16.7.2.4. UAE Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
Age Group
16.7.2.4.1. Pediatric
16.7.2.4.2. Adult
16.7.2.5. UAE Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By
End Users
16.7.2.5.1. Hospitals and Clinics
16.7.2.5.2. Diagnostic Centers
16.7.2.5.3. Ambulatory Surgical Centers
16.7.2.5.4. Research Institutions
16.7.2.5.5. Home Care
16.7.2.5.6. Others
16.7.3. Egypt
16.7.3.1. Egypt Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
16.7.3.1.1. Products
16.7.3.1.1.1. Devices
16.7.3.1.1.1.1. Cerebral Oximetry
16.7.3.1.1.1.2. Electroencephalogram (EEG) Systems
16.7.3.1.1.1.3. Electromyography (EMG) Systems
16.7.3.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
16.7.3.1.1.1.5. Brain Monitoring Sensors
16.7.3.1.1.1.6. Transcranial Doppler Devices
16.7.3.1.1.1.7. Magnetoencephalography (MEG) Systems
16.7.3.1.1.1.8. Others
16.7.3.1.1.2. Accessories
16.7.3.1.1.2.1. Cables and Connectors
16.7.3.1.1.2.2. Electrodes
16.7.3.1.1.2.3. Batteries
16.7.3.1.1.2.4. Application Gel
16.7.3.1.1.2.5. Others
16.7.3.1.2. Software
16.7.3.1.3. Services
16.7.3.1.3.1. Training
and Education
16.7.3.1.3.2. Support
Services
16.7.3.1.3.3. Others
16.7.3.2. Egypt Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
16.7.3.2.1. Sleep Disorder
16.7.3.2.2. Epilepsy
16.7.3.2.3. Brain Tumor
16.7.3.2.4. Stroke
16.7.3.2.5. Traumatic Brain Injury (TBI)
16.7.3.2.6. Others
16.7.3.3. Egypt Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.3.3.1. Invasive Procedure
16.7.3.3.2. Non-Invasive Procedure
16.7.3.4. Egypt Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
16.7.3.4.1. Pediatric
16.7.3.4.2. Adult
16.7.3.5. Egypt Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
16.7.3.5.1. Hospitals and Clinics
16.7.3.5.2. Diagnostic Centers
16.7.3.5.3. Ambulatory Surgical Centers
16.7.3.5.4. Research Institutions
16.7.3.5.5. Home Care
16.7.3.5.6. Others
16.7.4. Kuwait
16.7.4.1. Kuwait Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
16.7.4.1.1. Products
16.7.4.1.1.1. Devices
16.7.4.1.1.1.1. Cerebral Oximetry
16.7.4.1.1.1.2. Electroencephalogram (EEG) Systems
16.7.4.1.1.1.3. Electromyography (EMG) Systems
16.7.4.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
16.7.4.1.1.1.5. Brain Monitoring Sensors
16.7.4.1.1.1.6. Transcranial Doppler Devices
16.7.4.1.1.1.7. Magnetoencephalography (MEG) Systems
16.7.4.1.1.1.8. Others
16.7.4.1.1.2. Accessories
16.7.4.1.1.2.1. Cables and Connectors
16.7.4.1.1.2.2. Electrodes
16.7.4.1.1.2.3. Batteries
16.7.4.1.1.2.4. Application Gel
16.7.4.1.1.2.5. Others
16.7.4.1.2. Software
16.7.4.1.3. Services
16.7.4.1.3.1. Training
and Education
16.7.4.1.3.2. Support
Services
16.7.4.1.3.3. Others
16.7.4.2. Kuwait Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
16.7.4.2.1. Sleep Disorder
16.7.4.2.2. Epilepsy
16.7.4.2.3. Brain Tumor
16.7.4.2.4. Stroke
16.7.4.2.5. Traumatic Brain Injury (TBI)
16.7.4.2.6. Others
16.7.4.3. Kuwait Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.4.3.1. Invasive Procedure
16.7.4.3.2. Non-Invasive Procedure
16.7.4.4. Kuwait Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
16.7.4.4.1. Pediatric
16.7.4.4.2. Adult
16.7.4.5. Kuwait Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
16.7.4.5.1. Hospitals and Clinics
16.7.4.5.2. Diagnostic Centers
16.7.4.5.3. Ambulatory Surgical Centers
16.7.4.5.4. Research Institutions
16.7.4.5.5. Home Care
16.7.4.5.6. Others
16.7.5. South
Africa
16.7.5.1. South Africa Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
16.7.5.1.1. Products
16.7.5.1.1.1. Devices
16.7.5.1.1.1.1. Cerebral Oximetry
16.7.5.1.1.1.2. Electroencephalogram (EEG) Systems
16.7.5.1.1.1.3. Electromyography (EMG) Systems
16.7.5.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
16.7.5.1.1.1.5. Brain Monitoring Sensors
16.7.5.1.1.1.6. Transcranial Doppler Devices
16.7.5.1.1.1.7. Magnetoencephalography (MEG) Systems
16.7.5.1.1.1.8. Others
16.7.5.1.1.2. Accessories
16.7.5.1.1.2.1. Cables and Connectors
16.7.5.1.1.2.2. Electrodes
16.7.5.1.1.2.3. Batteries
16.7.5.1.1.2.4. Application Gel
16.7.5.1.1.2.5. Others
16.7.5.1.2. Software
16.7.5.1.3. Services
16.7.5.1.3.1. Training
and Education
16.7.5.1.3.2. Support
Services
16.7.5.1.3.3. Others
16.7.5.2. South Africa Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
16.7.5.2.1. Sleep Disorder
16.7.5.2.2. Epilepsy
16.7.5.2.3. Brain Tumor
16.7.5.2.4. Stroke
16.7.5.2.5. Traumatic Brain Injury (TBI)
16.7.5.2.6. Others
16.7.5.3. South Africa Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.5.3.1. Invasive Procedure
16.7.5.3.2. Non-Invasive Procedure
16.7.5.4. South Africa Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
16.7.5.4.1. Pediatric
16.7.5.4.2. Adult
16.7.5.5. South Africa Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.5.5.1. Hospitals and Clinics
16.7.5.5.2. Diagnostic Centers
16.7.5.5.3. Ambulatory Surgical Centers
16.7.5.5.4. Research Institutions
16.7.5.5.5. Home Care
16.7.5.5.6. Others
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest of Middle East & Africa Brain Monitoring Market
Revenue (US$ Mn) and Forecasts, By Component
16.7.6.1.1. Products
16.7.6.1.1.1. Devices
16.7.6.1.1.1.1. Cerebral Oximetry
16.7.6.1.1.1.2. Electroencephalogram (EEG) Systems
16.7.6.1.1.1.3. Electromyography (EMG) Systems
16.7.6.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
16.7.6.1.1.1.5. Brain Monitoring Sensors
16.7.6.1.1.1.6. Transcranial Doppler Devices
16.7.6.1.1.1.7. Magnetoencephalography (MEG) Systems
16.7.6.1.1.1.8. Others
16.7.6.1.1.2. Accessories
16.7.6.1.1.2.1. Cables and Connectors
16.7.6.1.1.2.2. Electrodes
16.7.6.1.1.2.3. Batteries
16.7.6.1.1.2.4. Application Gel
16.7.6.1.1.2.5. Others
16.7.6.1.2. Software
16.7.6.1.3. Services
16.7.6.1.3.1. Training
and Education
16.7.6.1.3.2. Support
Services
16.7.6.1.3.3. Others
16.7.6.2. Rest of Middle East & Africa Brain Monitoring Market
Revenue (US$ Mn) and Forecasts, By Disease Indication
16.7.6.2.1. Sleep Disorder
16.7.6.2.2. Epilepsy
16.7.6.2.3. Brain Tumor
16.7.6.2.4. Stroke
16.7.6.2.5. Traumatic Brain Injury (TBI)
16.7.6.2.6. Others
16.7.6.3. Rest of Middle East & Africa Brain Monitoring Market
Revenue (US$ Mn) and Forecasts, By Application
16.7.6.3.1. Invasive Procedure
16.7.6.3.2. Non-Invasive Procedure
16.7.6.4. Rest of Middle East & Africa Brain Monitoring Market
Revenue (US$ Mn) and Forecasts, By Age Group
16.7.6.4.1. Pediatric
16.7.6.4.2. Adult
16.7.6.5. Rest of Middle East & Africa Brain Monitoring Market
Revenue (US$ Mn) and Forecasts, By End Users
16.7.6.5.1. Hospitals and Clinics
16.7.6.5.2. Diagnostic Centers
16.7.6.5.3. Ambulatory Surgical Centers
16.7.6.5.4. Research Institutions
16.7.6.5.5. Home Care
16.7.6.5.6. Others
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Component
16.8.3. By
Disease Indication
16.8.4. By
Application
16.8.5. By Age
Group
16.8.6. By End
Users
17. Latin America Brain Monitoring Market Analysis and Forecasts,
2021 - 2029
17.1. Overview
17.1.1. Latin
America Brain Monitoring Market Revenue (US$ Mn)
17.2. Latin
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Component
17.2.1. Products
17.2.1.1. Devices
17.2.1.1.1. Cerebral Oximetry
17.2.1.1.2. Electroencephalogram (EEG) Systems
17.2.1.1.3. Electromyography (EMG) Systems
17.2.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
17.2.1.1.5. Brain Monitoring Sensors
17.2.1.1.6. Transcranial Doppler Devices
17.2.1.1.7. Magnetoencephalography (MEG) Systems
17.2.1.1.8. Others
17.2.1.2. Accessories
17.2.1.2.1. Cables and Connectors
17.2.1.2.2. Electrodes
17.2.1.2.3. Batteries
17.2.1.2.4. Application Gel
17.2.1.2.5. Others
17.2.2. Software
17.2.3. Services
17.2.3.1. Training and Education
17.2.3.2. Support Services
17.2.3.3. Others
17.3. Latin
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
17.3.1. Sleep
Disorder
17.3.2. Epilepsy
17.3.3. Brain
Tumor
17.3.4. Stroke
17.3.5. Traumatic
Brain Injury (TBI)
17.3.6. Others
17.4. Latin
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Application
17.4.1. Invasive
Procedure
17.4.2. Non-Invasive
Procedure
17.5. Latin
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Age Group
17.5.1. Pediatric
17.5.2. Adult
17.6. Latin
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By End Users
17.6.1. Hospitals
and Clinics
17.6.2. Diagnostic
Centers
17.6.3. Ambulatory
Surgical Centers
17.6.4. Research
Institutions
17.6.5. Home
Care
17.6.6. Others
17.7. Latin
America Brain Monitoring Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Component
17.7.1.1.1. Products
17.7.1.1.1.1. Devices
17.7.1.1.1.1.1. Cerebral Oximetry
17.7.1.1.1.1.2. Electroencephalogram (EEG) Systems
17.7.1.1.1.1.3. Electromyography (EMG) Systems
17.7.1.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
17.7.1.1.1.1.5. Brain Monitoring Sensors
17.7.1.1.1.1.6. Transcranial Doppler Devices
17.7.1.1.1.1.7. Magnetoencephalography (MEG) Systems
17.7.1.1.1.1.8. Others
17.7.1.1.1.2. Accessories
17.7.1.1.1.2.1. Cables and Connectors
17.7.1.1.1.2.2. Electrodes
17.7.1.1.1.2.3. Batteries
17.7.1.1.1.2.4. Application Gel
17.7.1.1.1.2.5. Others
17.7.1.1.2. Software
17.7.1.1.3. Services
17.7.1.1.3.1. Training
and Education
17.7.1.1.3.2. Support
Services
17.7.1.1.3.3. Others
17.7.1.2. Brazil Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
17.7.1.2.1. Sleep Disorder
17.7.1.2.2. Epilepsy
17.7.1.2.3. Brain Tumor
17.7.1.2.4. Stroke
17.7.1.2.5. Traumatic Brain Injury (TBI)
17.7.1.2.6. Others
17.7.1.3. Brazil Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Application
17.7.1.3.1. Invasive Procedure
17.7.1.3.2. Non-Invasive Procedure
17.7.1.4. Brazil Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By Age Group
17.7.1.4.1. Pediatric
17.7.1.4.2. Adult
17.7.1.5. Brazil Brain Monitoring Market Revenue (US$ Mn) and Forecasts,
By End Users
17.7.1.5.1. Hospitals and Clinics
17.7.1.5.2. Diagnostic Centers
17.7.1.5.3. Ambulatory Surgical Centers
17.7.1.5.4. Research Institutions
17.7.1.5.5. Home Care
17.7.1.5.6. Others
17.7.2. Argentina
17.7.2.1. Argentina Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Component
17.7.2.1.1. Products
17.7.2.1.1.1. Devices
17.7.2.1.1.1.1. Cerebral Oximetry
17.7.2.1.1.1.2. Electroencephalogram (EEG) Systems
17.7.2.1.1.1.3. Electromyography (EMG) Systems
17.7.2.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
17.7.2.1.1.1.5. Brain Monitoring Sensors
17.7.2.1.1.1.6. Transcranial Doppler Devices
17.7.2.1.1.1.7. Magnetoencephalography (MEG) Systems
17.7.2.1.1.1.8. Others
17.7.2.1.1.2. Accessories
17.7.2.1.1.2.1. Cables and Connectors
17.7.2.1.1.2.2. Electrodes
17.7.2.1.1.2.3. Batteries
17.7.2.1.1.2.4. Application Gel
17.7.2.1.1.2.5. Others
17.7.2.1.2. Software
17.7.2.1.3. Services
17.7.2.1.3.1. Training
and Education
17.7.2.1.3.2. Support
Services
17.7.2.1.3.3. Others
17.7.2.2. Argentina Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
17.7.2.2.1. Sleep Disorder
17.7.2.2.2. Epilepsy
17.7.2.2.3. Brain Tumor
17.7.2.2.4. Stroke
17.7.2.2.5. Traumatic Brain Injury (TBI)
17.7.2.2.6. Others
17.7.2.3. Argentina Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Application
17.7.2.3.1. Invasive Procedure
17.7.2.3.2. Non-Invasive Procedure
17.7.2.4. Argentina Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By Age Group
17.7.2.4.1. Pediatric
17.7.2.4.2. Adult
17.7.2.5. Argentina Brain Monitoring Market Revenue (US$ Mn) and
Forecasts, By End Users
17.7.2.5.1. Hospitals and Clinics
17.7.2.5.2. Diagnostic Centers
17.7.2.5.3. Ambulatory Surgical Centers
17.7.2.5.4. Research Institutions
17.7.2.5.5. Home Care
17.7.2.5.6. Others
17.7.3. Rest of
Latin America
17.7.3.1. Rest of Latin America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Component
17.7.3.1.1. Products
17.7.3.1.1.1. Devices
17.7.3.1.1.1.1. Cerebral Oximetry
17.7.3.1.1.1.2. Electroencephalogram (EEG) Systems
17.7.3.1.1.1.3. Electromyography (EMG) Systems
17.7.3.1.1.1.4. Polysomnographic (PSG) Amplifiers and Recorders
17.7.3.1.1.1.5. Brain Monitoring Sensors
17.7.3.1.1.1.6. Transcranial Doppler Devices
17.7.3.1.1.1.7. Magnetoencephalography (MEG) Systems
17.7.3.1.1.1.8. Others
17.7.3.1.1.2. Accessories
17.7.3.1.1.2.1. Cables and Connectors
17.7.3.1.1.2.2. Electrodes
17.7.3.1.1.2.3. Batteries
17.7.3.1.1.2.4. Application Gel
17.7.3.1.1.2.5. Others
17.7.3.1.2. Software
17.7.3.1.3. Services
17.7.3.1.3.1. Training
and Education
17.7.3.1.3.2. Support
Services
17.7.3.1.3.3. Others
17.7.3.2. Rest of Latin America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Disease Indication
17.7.3.2.1. Sleep Disorder
17.7.3.2.2. Epilepsy
17.7.3.2.3. Brain Tumor
17.7.3.2.4. Stroke
17.7.3.2.5. Traumatic Brain Injury (TBI)
17.7.3.2.6. Others
17.7.3.3. Rest of Latin America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Application
17.7.3.3.1. Invasive Procedure
17.7.3.3.2. Non-Invasive Procedure
17.7.3.4. Rest of Latin America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By Age Group
17.7.3.4.1. Pediatric
17.7.3.4.2. Adult
17.7.3.5. Rest of Latin America Brain Monitoring Market Revenue (US$ Mn)
and Forecasts, By End Users
17.7.3.5.1. Hospitals and Clinics
17.7.3.5.2. Diagnostic Centers
17.7.3.5.3. Ambulatory Surgical Centers
17.7.3.5.4. Research Institutions
17.7.3.5.5. Home Care
17.7.3.5.6. Others
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Component
17.8.3. By
Disease Indication
17.8.4. By
Application
17.8.5. By Age
Group
17.8.6. By End
Users
18. Competitive Benchmarking
18.1. Brand
Benchmarking
18.2. Market
Share Analysis, 2020
18.3. Global
Presence and Growth Strategies
18.3.1. Mergers
and Acquisitions
18.3.2. Product
Launches
18.3.3. Investments
Trends
18.3.4. R&D
Initiatives
19. Player Profiles
19.1. Advanced
Brain Monitoring, Inc.
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Compumedics
Limited
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business Strategies
19.3. EMOTIV
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. GE Healthcare
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Koninklijke Philips N.V.
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. Masimo
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. Medtronic
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Natus Medical Incorporated
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. Neurosoft
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. Nihon Kohden Corporation
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Other Market Participants
20. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.